Novo Nordisk partners with OpenAI as AI drug discovery hopes mount
The partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs.
Novo Nordisk partners with OpenAI as AI drug discovery hopes mount basliginda one cikan gelisme: The partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs.
Fonvera editor notu: Haberin piyasa etkisini izlemek icin ilgili varlik sayfalari ve ekonomik takvim akisi birlikte okunmalidir.